Analysts think LAB stock price could increase by 59%
Aug 01, 2024, 6:25 AM
-5.78%
What does LAB do
Standard BioTools Inc., based in South San Francisco, California, offers biotechnology tools and services for clinical research, focusing on proteomics and genomics through technologies like mass cytometry and microfluidics. The company, which employs 523 people and went public in 2011, collaborates globally with various research sectors including oncology and immunology.
4 analysts think LAB stock price will increase by 58.67%. The current median analyst target is $3.57 compared to a current stock price of $2.25. The lowest analysts target is $3.28 and the highest analyst target is $4.20.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
